This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John E. Gerich, MD

Arch Intern Med. 1985;145(8):1383-1384.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the last ten years, there has been a substantial accumulation of evidence indicating that poor metabolic control plays an important role in the development of the so-called long-term complications of diabetes (retinopathy, neuropathy, nephropathy, and premature atherosclerosis).¹ On the basis of this evidence, the American Diabetes Association has recently recommended that "it is logical and prudent to reduce blood glucose levels to normal if such attempts are not grossly disturbing to the lifestyle of the patient."² Self-monitoring of blood glucose levels,³ mimicking of normal insulin secretory patterns by preprandial administration of insulin—so-called intensive insulin therapy,⁴ and use of glycosylated hemoglobin determination for objective evaluation of long-term control⁵ have made achievement of near normoglycemia a practical goal for most patients taking insulin.

In intensive insulin programs, meal-related and overnight insulin requirements are usually met either by use of pumps (continuous subcutaneous insulin infusion) or by . . . [Full Text PDF of this Article]

Author Affiliations
Department of Medicine and Physiology Endocrine Research Unit Mayo Clinic Rochester, MN 55905

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?